Status:
UNKNOWN
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Assiut University
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
* Assess the differences between flow and volume responses after bronchodilator reversibility testing in patients over different clinical chronic obstructive pulmonary disease stages (GOLD stage I to ...
Detailed Description
chronic obstructive pulmonary disease is a common preventable and treatable disease characterized by persistent airflow limitation that is usually progressive. The diagnosis requires an evidence of ob...
Eligibility Criteria
Inclusion
- Patients Clinical diagnosis of Chronic Obstructive Pulmonary Disease
- Must be able to do pulmonary function test
- Age more than 40 years
- Stable Chronic Obstructive Pulmonary Disease patients
Exclusion
- Any patients with a diagnosis of:
- Bronchial asthma
- Bronchiectasis
- Respiratory failure
- Decompensated core pulmonale
- Chronic Obstructive Pulmonary Disease combined with any other respiratory disease
Key Trial Info
Start Date :
September 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03282526
Start Date
September 30 2017
End Date
December 1 2018
Last Update
September 14 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.